Tumor Necrosis Factor Polymorphism Affects Transplantation Outcome in Patients with Myelodysplastic Syndrome but Not in Those with Chronic Myelogenous Leukemia, Independent of the Presence of HLA-DR15

Autor: Newell, Laura F.1,2, Gooley, Ted1,3, Hansen, John A.1,2, Stirewalt, Derek L.1,2, Petersdorf, Effie W.1,2, Deeg, H. Joachim1,2 jdeeg@fhcrc.org
Zdroj: Biology of Blood & Marrow Transplantation. Dec2010, Vol. 16 Issue 12, p1700-1706. 7p.
Databáze: Academic Search Ultimate
Externí odkaz: